Metastatic Neoplasm
Oncology
3
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
SanofiVociprotafib
Merck & Co.MK-8294
Clinical Trials (2)
Total enrollment: 132 patients across 2 trials
Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies
Start: Jun 2020Est. completion: Apr 202465 patients
Phase 1/2Terminated
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Start: Jul 2025Est. completion: Aug 202767 patients
Phase 1Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
2m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
2m ago
Office Administrator
SystImmune
2m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
13m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
16m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
16m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 132 patients
3 companies competing in this space